Risedronate significantly reduces vertebral and non-vertebral fractures in osteoporotic women.

被引:0
|
作者
Roux, C
Keller, M
Eastell, R
McKeever, C
Pack, S
Ethgen, D
Reginster, JY
Chestnut, C
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SU428
引用
收藏
页码:S538 / S538
页数:1
相关论文
共 50 条
  • [1] Risedronate significantly reduces both vertebral and non-vertebral fractures in osteoporotic women.
    Roux, C
    Boling, E
    Baylink, D
    Bonnick, S
    Pack, S
    Ethgen, D
    Eastell, R
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S118 - S118
  • [2] Risedronate significantly reduces non-vertebral fractures in osteoporotic women
    Reid, D
    Eastell, R
    Doherty, S
    Roux, C
    Keller, M
    McKeever, C
    Pack, S
    Ethgen, D
    Reginster, JY
    Chesnut, C
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S27 - S27
  • [3] Risedronate significantly reduces the risk of non-vertebral fractures in postmenopausal osteoporotic women in just one year.
    Bolognese, M
    Fogelman, I
    Guesens, P
    Hanley, DA
    Barton, I
    Bettica, P
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
  • [4] Risedronate reduces the risk of non-vertebral fractures in osteoporotic postmenopausal women as soon as 6 months
    Boonen, S
    Brandi, ML
    Harrington, T
    Barton, I
    Ste-Marie, LG
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S15 - S16
  • [5] RISEDRONATE REDUCES THE RISK OF NON-VERTEBRAL FRACTURES FASTLY AND EFFECTIVELY
    不详
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2006, 13 (01): : 36 - 36
  • [6] Risedronate reduces the risk of clinical vertebral fractures as early as 6 months and non-vertebral fractures as early as 12 months in women with postmenopausal osteoporosis.
    Bolognese, M
    Chesnut, C
    Adami, S
    Barton, I
    Watts, N
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S254 - S254
  • [7] THE COSTS OF NON-VERTEBRAL OSTEOPOROTIC FRACTURES IN THE UNITED STATES
    Birnbaum, H. G.
    Pike, C.
    Schiller, M.
    Sharma, H.
    Gu, A.
    Burge, R. T.
    Edgell, E. T.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A68 - A69
  • [8] Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with postmenopausal osteoporosis
    Adami, S
    Meunier, PJ
    Devogelaer, JP
    Hoszowski, K
    Fardellone, P
    Benhamou, V
    Brixen, K
    Bonidan, O
    Marcelli, C
    Reginster, JY
    Fechtenbaum, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S93 - S94
  • [9] Risedronate significantly reduces the risk of new vertebral fractures, in women irrespective of the number of prevalent vertebral fractures in just one year
    Eastell, R
    Compston, J
    Roux, C
    Alsayed, N
    Barton, I
    [J]. BONE, 2001, 28 (05) : S225 - S225
  • [10] Risedronate Reduces the Risk of First Vertebral Fracture in Osteoporotic Women
    R. P. Heaney
    T. M. Zizic
    I. Fogelman
    W. P. Olszynski
    P. Geusens
    C. Kasibhatla
    N. Alsayed
    G. Isaia
    M. W. Davie
    C. H. Chesnut III
    [J]. Osteoporosis International, 2002, 13 : 501 - 505